Cannabis, schizophrenia genetic risk, and psychotic experiences: a cross-sectional study of 109,308 participants from the UK Biobank
M. Wainberg, G. R. Jacobs, et al.
Explore these studies to deepen your understanding
Adjacent work that informs or extends this paper's methodology and findings.
The effects of polygenic risk for psychiatric disorders and smoking behaviour on psychotic experiences in UK Biobank
J. García-gonzález, J. Ramírez, et al.
Educational attainment reduces the risk of suicide attempt among individuals with and without psychiatric disorders independent of cognition: a bidirectional and multivariable Mendelian randomization study with more than 815,000 participants
D. B. Rosoff, Z. A. Kaminsky, et al.
Psychiatric polygenic risk as a predictor of COVID-19 risk and severity: insight into the genetic overlap between schizophrenia and COVID-19
M. Alemany-navarro, S. D. Almeida, et al.
Investigating biological sex as a moderator of the association of nature exposure with brain health: a cross-sectional UK biobank analysis
M. Noseworthy, R. S. Falck, et al.
